Singclean Medical will participate in the Aesthetic & Anti-Aging Medicine World Congress (AMWC) 2026, taking place from March 26 to 28, 2026, at the Grimaldi Forum in Monaco. As one of the most influential global events in aesthetic medicine, AMWC gathers leading physicians, researchers, and industry pioneers to exchange insights on cutting-edge technologies and emerging trends.

At this year’s congress, Singclean Medical will welcome visitors at Booth H21 (Diaghilev Area), presenting its latest advancements in injectable and regenerative aesthetic solutions. The company continues to strengthen its global presence by delivering clinically driven, innovation-focused products tailored to evolving market demands.

Singclean’s featured portfolio will include a comprehensive range of aesthetic products, such as cross-linked hyaluronic acid (HA) fillers, PLLA-based biostimulators, and PDRN skincare solutions. These offerings are designed to address a wide spectrum of clinical applications, from facial contouring and volumization to skin regeneration and post-procedure recovery.

Among these, regenerative aesthetics remains a key highlight. Singclean’s PLLA-based biostimulator products are engineered to promote collagen neogenesis, supporting long-term tissue remodeling and natural-looking results. This category has gained significant traction worldwide, reflecting a growing shift toward treatments that combine immediate outcomes with sustained biological benefits.

In addition to product showcases, Singclean Medical will actively engage in professional exchanges throughout the congress, fostering collaboration with dermatologists, plastic surgeons, and distribution partners from across the globe. The company aims to further expand its international network while advancing localized market strategies in key regions.

With products already distributed in over 30 countries and regions, Singclean Medical continues to build a strong reputation for quality, safety, and innovation. Its participation in AMWC 2026 underscores the company’s commitment to contributing to the global aesthetic medicine landscape and supporting practitioners with reliable, high-performance solutions.

Looking ahead, Singclean Medical remains dedicated to continuous R&D investment and clinical validation, striving to deliver next-generation aesthetic technologies that meet both physician expectations and patient needs.